Cleared Traditional

K940430 - SEDRATROL

K940430 is an FDA 510(k) clearance for SEDRATROL, manufactured by Medical Specialties Intl., Inc.. The device is a Class 2 Hematology device with product code GJR cleared through the Traditional 510(k) pathway after a 371-day FDA review.

K940430 · Medical Specialties Intl., Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1995
Decision
371d
Days
Class 2
Risk

K940430 is an FDA 510(k) clearance for the SEDRATROL. Classified as Control, Red-cell (product code GJR), Class II - Special Controls.

Submitted by Medical Specialties Intl., Inc. (South Plainfield, US). The FDA issued a Cleared decision on February 6, 1995 after a review of 371 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.8625 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medical Specialties Intl., Inc. devices

FDA 510(k) Submission Details - K940430

510(k) Number K940430 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 1994
Decision Date February 06, 1995
Days to Decision 371 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
258d slower than avg
Panel avg: 113d · This submission: 371d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GJR Device Classification - Class 2, Special Controls

Product Code GJR Control, Red-cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.8625
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.